Siniscalco D - Search Results

1

Possible use of Trichuris suis ova in autism spectrum disorders therapy.

Siniscalco D, Antonucci N. Siniscalco D, et al. Med Hypotheses. 2013 Jul;81(1):1-4. doi: 10.1016/j.mehy.2013.03.024. Epub 2013 Apr 15. Med Hypotheses. 2013. PMID: 23597946 Review.

2

Neuropathic pain: is the end of suffering starting in the gene therapy?

Siniscalco D, de Novellis V, Rossi F, Maione S. Siniscalco D, et al. Curr Drug Targets. 2005 Feb;6(1):75-80. doi: 10.2174/1389450053344966. Curr Drug Targets. 2005. PMID: 15720215 Review.

3

Stem cell therapy: the great promise in lung disease.

Siniscalco D, Sullo N, Maione S, Rossi F, D'Agostino B. Siniscalco D, et al. Among authors: d agostino b. Ther Adv Respir Dis. 2008 Jun;2(3):173-7. doi: 10.1177/1753465808092340. Ther Adv Respir Dis. 2008. PMID: 19124369 Review.

4

Transplantation of human mesenchymal stem cells in the study of neuropathic pain.

Siniscalco D. Siniscalco D. Methods Mol Biol. 2010;617:337-45. doi: 10.1007/978-1-60327-323-7_25. Methods Mol Biol. 2010. PMID: 20336433

5

Novel insights in basic and applied stem cell therapy.

Siniscalco D, Giordano A, Galderisi U. Siniscalco D, et al. J Cell Physiol. 2012 May;227(5):2283-6. doi: 10.1002/jcp.22945. J Cell Physiol. 2012. PMID: 21780112

6

The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients.

Siniscalco D, Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, Fasano A, Maione S, Antonucci N. Siniscalco D, et al. J Autism Dev Disord. 2012 Jul;42(7):1403-10. doi: 10.1007/s10803-011-1373-z. J Autism Dev Disord. 2012. PMID: 21969075

7

Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, Maione S. Siniscalco D, et al. Front Integr Neurosci. 2011 Dec 1;5:79. doi: 10.3389/fnint.2011.00079. eCollection 2011. Front Integr Neurosci. 2011. PMID: 22164136 Free PMC article.

8

Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. Siniscalco D, et al. J Biomed Biotechnol. 2012;2012:480289. doi: 10.1155/2012/480289. Epub 2012 Feb 13. J Biomed Biotechnol. 2012. PMID: 22496609 Free PMC article. Review.

9

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N. Siniscalco D, et al. J Autism Dev Disord. 2013 Nov;43(11):2686-95. doi: 10.1007/s10803-013-1824-9. J Autism Dev Disord. 2013. PMID: 23585028

10

Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.

Siniscalco D, Bradstreet JJ, Antonucci N. Siniscalco D, et al. Front Immunol. 2013 Jun 10;4:140. doi: 10.3389/fimmu.2013.00140. eCollection 2013. Front Immunol. 2013. PMID: 23772227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results